Mynosys CEO Hendrick Lays Out Next Step for Zepto Following Positive FDA, Strong OUS Launch
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 139″]
Mynosys Cellular Devices CEO and president John Hendrick lays out his company’s plan to roll out Zepto in the US. The firm has reported strong demand in OUS markets, and Hendrick anticipates it will upend the capsulotomy market.
Podcast Guest:
John Hendrick
Mr. Hendrick has over three decades of executive experience, building both early stage medical device companies as well as large divisions in medical device corporations.